Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering.Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development…
Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering.Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development…